Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults

IntroductionThe human respiratory syncytial virus (hRSV) is responsible for most respiratory tract infections in infants. Even though currently there are no approved hRSV vaccines for newborns or infants, several candidates are being developed. rBCG-N-hRSV is a vaccine candidate previously shown to...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Gaspar A. Pacheco, Catalina A. Andrade, Nicolás M.S. Gálvez, Yaneisi Vázquez, Linmar Rodríguez-Guilarte, Katia Abarca, Pablo A. González, Susan M. Bueno, Alexis M. Kalergis
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2023-07-01
coleção:	Frontiers in Immunology
Assuntos:	hRSV vaccine BCG clinical trial cellular response
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1215893/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!